References

1. 1.
   DROSSMAN D A， HASLER W L. Rome Ⅳ-functional GI disorders： Disorders of gut-brain interaction［J］. Gastroenterology， 2016，150（6）：1257-1261.
2. 2.
   LI S Q， HU Y L， SU C X， et al. Sishenwan ameliorates visceral sensitivity in rat model of diarrhea-predominant irritable bowel syndrome （spleen-kidney Yang deficiency） by regulating p38 MAPK/JNK/TRPV1 pathway［J］. Chin J Exp Tradit Med Form， 2024 ，30 （21） ：10-18.
3. 3.
   GAMAGE P， PATEL B A， YEOMAN M S， et al. Interstitial cell network volume is reduced in the terminal bowel of ageing mice［J］. J Cell Mol Med， 2018，22（10）：5160-5164.
4. 4.
   HUANG L， ZHU Q， QU X， et al. Microbial treatment in chronic constipation［J］. Sci China Life Sci， 2018，61（7）：744-752.
5. 5.
   Study Group of Functional Gastrointestinal Disorders，Study Group of Gastrointestinal Motility Chinese Society of Gastroenterology，Chinese Medical Association. Chinese expert consensus of irritable bowel syndrome in 2020［J］. Chin J Digest， 2020，40（12）：803-818.
6. 6.
   HU Z， LI M， YAO L， et al. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome： A network Meta-analysis［J］. BMC Gastroenterol， 2021，21（1）：23.
7. 7.
   LU Z K， XIE Y M. Clinical comprehensive evaluation of tongxiening granules in treatment of diarrhea-predominant irritable bowel syndrome with liver Qi invading spleen syndrome［J］. Chin J Exp Tradit Med Form， 2024，30（11）：139-149.
8. 8.
   LI Y D， ZHANG S X， XU Y X， et al. Effect of Buzhong Yiqi decoction in the treatment of irritable bowel syndrome with constipation［J］. Jilin J Chin Med， 2024，44（6）：687-691.
9. 9.
   LIU J Q， LIU R H， WU C D， et al. Clinical observation on treatment of constipation irritable bowel syndrome of stagnation of liver Qi syndrome with Jianpi Shugan pill［J］. Beijing J Tradit Chin Med， 2023，42（4）：394-397.
10. 10.
    BAO Y R， WANG C J. TCM diagnosis and treatment of constipation-type irritable bowel syndrome［J］. J China Prescrip Drug， 2024，22（3）：159-162.
11. 11.
    SONG Y J. Evaluation of the curative effect of Tong Fu Kuanzhong decoction in treating functional constipation with anxietyand/or depression and influence on colonic electrical activity［D］. Jinan： Shandong University of Traditional Chinese Medicine， 2022.
12. 12.
    SONG Y J， LIU S X， WANG S， et al. Curative effect and mechanism of Tongfu Kuanzhong decoction combined with biofeedback on defecation disorder constipation［J］. Mod J Integr Tradit Chin West Med， 2022，31（14）：1928-1933.
13. 13.
    LIU S X. Evaluation of the curative effect of Chinese herbal compound combined with biofeedback in the treatment of constipation and its influence on anorectal manometry parameters［D］. Jinan： Shandong University of Traditional Chinese Medicine， 2021.
14. 14.
    MEARIN F， LACY B E， CHANG L， et al. Bowel disorders［J］. Gastroenterol， 2016，doi： .
15. 15.
    ZHANG S S， SHENG H， ZHANG X， et al. Expert consensus opinion on Chinese medicine diagnosis and treatment of constipation （2017） ［J］. J Tradit Chin Med， 2017，58（15）：1345-1350.
16. 16.
    ZHENG X Y. Guiding principles for clinical research of new drugs of traditional Chinese medicine （ Trial ） ［ M ］.Beijing ： China Pharmaceutical Science and Technology Press， 2002 ： 139-143.
17. 17.
    National Bureau of Technical Supervision. Clinical diagnosis and treatment of traditional Chinese medicine terminology ： syndrome part ［M］.Beijing ： China Standard Press， 1997.
18. 18.
    WANG X R， FU W B， SUN Y Q， et al. Clinical efficacy of Tongxie Yaofang on diarrhea-predominant irritable bowel syndrome（IBS-D） patients with liver depression and spleen deficiency［J］. Chin J Exp Tradit Med Form， 2022，28（9）：97-102.
19. 19.
    LUO T， SUN R， ZHANG L， et al. Analysis of medication rules for treating constipation-type irritable bowel syndrome with liver depression and Qi stagnation by traditional Chinese medicine［J］. China Mod Med， 2024， 31（10）：10-15，21.
20. 20.
    GAO F， LIU T G， BAI C， et al. The research of the correlation between brain-gut axis and gastrointestinal motility［J］. J Tianjin Univ Tradit Chin Med， 2018，37（6）：520-524.
21. 21.
    ZHU D L. Clinical study on psychological state and gastrointestinal dynamics of patients with lBS-C syndrome of liver depressionand Qi stagnation treated with "preseription for regulating Qi and clearing heat"［D］. Nanning： Guangxi University of Chinese Medicine， 2018.
22. 22.
    Medicine Expert Group of Psychosomatic. Expert consensus on clinical application of Shugan Jieyu capsule in treatment of mild to moderate depressive disorders［J］. J Beijing Univ Tradit Chin Med， 2021，44（11）：969-977.
23. 23.
    BAO Z H， GUO T， ZHANG K， et al. The effect and mechanism of Shuganjieyu capsule combined with Escitalopram in treatment of senile depression with insomnia ［J］. Mod J Integr Tradit Chin West Med， 2020，29（30）：3385-3389.
24. 24.
    CAMILLERI M， BOECKXSTAENS G. Irritable bowel syndrome： Treatment based on pathophysiology and biomarkers［J］. Gut， 2023，72（3）：590-599.
25. 25.
    XIANG X L， HOU X H， CHEN M H， et al. Clinical guidelines for high-resolution anorectal manometry in Chinese adults［J］. Chin J Gastroenterol， 2023，28（10）：608-615.
26. 26.
    LI Y. The effect and machanism of sennoside A on promoting intestinal motility［D］. Xian： Air Force Medical University， 2019.
27. 27.
    ZHONG F， CHEN M， REN C， et al. Comparison of the immediate effects of different acupoints combination stimulate bowel movements in healthy volunteers［J］. China J Tradit Chin Med Pharm， 2013，28（11）：3227-3231.
28. 28.
    CHEN D L， WANG Z G， WANG Z G， et al. Mechanism of Taipo granules in the treatment of slow transit constipation［J］. Chin J Integr Tradit West Med Digest， 2010，18（5）：303-305.
29. 29.
    SUN X R， CHI L L， CAO Z Q， et al. Electroencephalography observation before and after Chinese medicine treatment for constipation ［J］. Shandong J Tradit Chin Med， 1995（9）：399.